US-based pharmaceutical giant McKesson is setting up a service center in Vilnius.
According to information from the Center of Registers, McKesson Business Services Lithuania was registered on Wednesday with an authorized share capital of 5 million euros and Ildiko By as its CEO.
The new company is wholly owned by McKesson’s European unit, Germany-registered McKesson Europe Holdings.
McKesson, one of the largest pharmaceutical businesses in the US, ranked 13th among the world’s largest companies by 2018 revenue, next to Apple, Glencore, Samsung, and others.
McKesson posted 208.4 billion US dollars in revenue for the 2017-2018 financial year, up 5 percent from 198.5 billion dollars a year earlier.
